News, trends, and stories from the synthetic biology industry

Hi all,

Thank you to Battelle for sponsoring this week's newsletter. The company created the ThreatSEQ DNA Screening Web Service, a tool designed to screen and identify potentially dangerous DNA sequences that gene synthesis companies might receive. The ThreatSEQ platform aims to keep researchers safe and to prevent concerning genes, like those from smallpox, from falling into the wrong hands. Learn more at Battelle.org

This week, Jake Glanville announced that Charles River Laboratories acquired Distributed Bio, congratulations to the team! A year ago, as COVID-19 began to wreak havoc on the world, Jake Glanville, Sara Ives, and the team at Distributed Bio were featured in the first season of Netflix’s “Pandemic: How to Prevent an Outbreak.” Now, Jake will move forward with his second venture, Centivax, focused on therapeutics, COVID-19, universal vaccines, and more.

Jake Glanville speaking at SynBioBeta.

In other news, Ginkgo Bioworks announced the launch of its pilot program to bring COVID-19 pooled testing to K-12 schools across the U.S. at no cost. The program is part of Ginkgo’s COVID-19 testing service, Concentric by Ginkgo, designed to enable low-cost and large-scale testing for schools, businesses, and communities as they look to reopen.

BioBuilder partners with Niswonger Foundation on $8.8M federal grant for STEM education
BioBuilder will provide teacher professional development in the area of synthetic biology through their Essentials and Master Teacher workshops.

Have a great week,

Regards 
John

Latest News

We built a 2020 time capsule out of synthetic DNA — here’s how (The Verge)

2020 was a breakout year for CRISPR: Between glimpses of a medical cure and winning science’s shiniest prize, this proved to the gene-editing technology’s biggest year yet (WIRED)

Amyris announces Bonsucro certification sustainable sugarcane production for clean ingredients (Press release)

Expanding the boundaries of CO2 fixation: Design and realization of synthetic enzymes open up an alternative to natural photorespiration (Max Planck Society)

Aleph Farms and Mitsubishi bring cultivated meat to Japan (Medium)

The first pig-to-human organ transplants could happen this year (Future Human)

Who's hiring?

Technical & Marketing Writer: Inscripta – Boulder, CO

 

Bioinformatics Scientist: Inscripta – Pleasanton, CA

 

Field Service Engineer: Inscripta – North America East

 

Field Applications Scientist: Inscripta – Europe

 

André Hoffmann Fellow (Security, Governance and Emerging Technologies for Precision Medicine): Stanford University – California

 

Postdoc Fellowship (Biotechnology Innovation & International Security): Stanford University – California

 

Senior Bioprocess Engineer/Manager: Culture Biosciences – South San Francisco, CA

 

Account Executive: Inscripta – UK and BNL

 

Scientist (Enzyme Engineering): Inscripta – Pleasanton, CA

 

Staff Scientist (Mammalian Cell Biology): Inscripta – Boulder, CO

 

Principal Synthetic Biologist: MITRE – McLean, VA

 

Principal Computational Systems Biologist: MITRE – McLean, VA

 

Biologist: Cambridge Consultants – Boston

 

Research Associate/Analyst: Johns Hopkins Center for Health Security – Baltimore, Maryland

 

Senior Scientist – Analytical Biochemistry: Inscripta – Pleasanton, California

 

University of California: Associate Teaching Professor of Bioengineering – Santa Cruz, California

 

Application Scientist: Codex DNA – San Diego, California

 

Feature your job here